Daniel Ek’s Neko Health Raises $700 Million For Preventive Health Tech

logo

Stockholm-based healthtech company Neko Health raises $700 million in series C funding. Neko has a mission to create a new healthcare system centered on early detection and disease prevention. The firm was founded by Daniel Ek the co-founder of Spotify.

Neko Health aims to take its futuristic medical scanning technology global. The $700M funding round led by Lightspeed Venture Partners propels Neko Health to a valuation of nearly $7 billion. This represents a massive jump from its $1.7 billion valuation in early 2025. 

The Neko Health 60-Minute Scan

The interior of a futuristic Neko Health scan room featuring a glowing circular platform on the floor and matching light fixture on the ceiling, with suspended white sensor hardware and the minimalist "NEKO" brand logo overlaid in the center.The interior of a futuristic Neko Health scan room featuring a glowing circular platform on the floor and matching light fixture on the ceiling, with suspended white sensor hardware and the minimalist "NEKO" brand logo overlaid in the center.

Neko Health Preventive Scan Room

The Neko Health project is based on a futuristic 60-minute scan. Envision a contemporary, relaxing clinic with a body scan that takes about an hour and is completely non-invasive and radiation free. 

The scan is priced at £299 in the UK and 2,750 SEK in Sweden. The Neko scan is made possible with custom-made sensors and rapid blood testing. This assesses cardiovascular, metabolic and skin health. It examines closely into moles, looks for pre-diabetes and the risk factors that can lead to a stroke. 

In just minutes, you have a detailed digital map of your body. Best of all, you can talk about the results right away with a face-to-face doctor. This is a solution to the stressful waiting periods in the conventional medical system. More than 100,000 members already have.

More Updates: Fintech Super App Flex Raises $70M At $1.2B

High-Definition Upgrades and the In-House Advantage

Unlike many health companies, Neko owns every single part of its tech stack. They build their own hardware and software in Sweden. Just last month, Neko rolled out its newest clinical devices: Derma-2, Echo-2, and Spectrum-2. 

These upgraded machines capture a much higher volume of biological signals across your skin, heart, and circulation. They also added instant body composition analysis and clinician wearable data reviews to the experience. 

This deepens the continuous picture of a user’s health. Because of this in-house focus, the team can automate operations and quickly roll out upgrades across all clinics.

More Updates: PixVerse Raises $439M To Build Real-Time Interactive Worlds

Big AI Beliefs As Neko Enters the US Market

Neko Health co-founders Hjalmar Nilsonne (leaning against a wall on the left in a beige t-shirt) and Daniel Ek (sitting on a bench on the right in a black t-shirt and glasses) posing in a minimalist, clean clinic corridor with a translucent, glowing gold glass door in the background.Neko Health co-founders Hjalmar Nilsonne (leaning against a wall on the left in a beige t-shirt) and Daniel Ek (sitting on a bench on the right in a black t-shirt and glasses) posing in a minimalist, clean clinic corridor with a translucent, glowing gold glass door in the background.

Founders Hjalmar Nilsonne and Daniel Ek.: Neko Health

The $700M Neko raised didn’t just come from venture capital. The startup saw funding from tech giants like Mark Zuckerberg and Priscilla Chan. They also received funding from celebrities like Maria Sharapova, Thierry Henry, will.i.am and Tim Ferriss. 

Even Hollywood heavyweight Ari Emanuel and music executive Jimmy Iovine backed the round. Investors are highly excited because Neko sits beautifully at the intersection of AI and is entering the U.S. market. After proving the model in Sweden and London, Neko is preparing for its biggest challenge yet. 

Neko plans to open its first U.S. clinics in New York later this year. The startup has already received FDA clearance for several core products. Ek, who stepped down as Spotify’s CEO earlier, is applying his classic international music-streaming expansion playbook to healthcare. 

Admitting it’s difficult to go from Sweden to the UK, he said, it will be ten times more difficult to deal with the complex U.S. healthcare landscape. Yet, there are more than 350,000 people on the waiting list and the need is clear.

The platform is already showing measurable results. Early detection has translated into real life improvements, with three out of four returning members keeping their flagged conditions safely under control.

More Updates: Valarian Raises $50 Million To Deliver Sovereign AI

EkeminiEkemini

Ekemini

I’m a crypto writer with 4+ years of experience passionate about turning big, technical ideas into content anyone can understand. From blockchain to stablecoins to everything in between, I enjoy helping readers stay informed in a space that never stops moving.



Source link

Leave a Reply